Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance.
Syria LapercheClaire SauvagePierre GallianSaadia JbilouElodie PoucholJean Yves PyLila ChabliPascale RichardPascal MorelFlorence LotPierre TiberghienPublished in: Vox sanguinis (2023)
HIV, HCV and HBV incidence rates in blood donors declined over the two past decades in France. There is a very small risk of a blood component that tests negative entering the blood supply resulting in TT infections, especially after introduction of molecular assays in donor screening.